Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
The drug costs about 2,750 euros per year per patient
Youve likely heard their names in the news or on social media: Ozempic, Wegovy, and the newest contender, Zepbound (Tirzepatide)
GLP-1 Market Key Players AstraZeneca Boehringer Ingelheim D&D Pharmatech Eli Lilly Hanmi Pharmaceutical Novo Nordisk Pfizer Roche Sanofi Tonghua Dongbao Pharmaceutical GLP-1 Pipeline Phases The GLP-1 agonists industry is evolving with key players advancing candidates through clinical stages for obesity, diabetes, and cardiometabolic indications
Food and Drug Administrations compassionate use program, according to STAT News
Not just on training days
US$ 25.59
US$ 26.05
US$ 28.46
US$ 20.14
US$ 22.25
US$ 23.06
US$ 25.67
